BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17889645)

  • 41. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
    Miao ZH; Agama K; Sordet O; Povirk L; Kohn KW; Pommier Y
    DNA Repair (Amst); 2006 Dec; 5(12):1489-94. PubMed ID: 16935573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA single-strand break repair and spinocerebellar ataxia.
    Caldecott KW
    Cell; 2003 Jan; 112(1):7-10. PubMed ID: 12526788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of APTX nicked DNA sensing and pleiotropic inactivation in neurodegenerative disease.
    Tumbale P; Schellenberg MJ; Mueller GA; Fairweather E; Watson M; Little JN; Krahn J; Waddell I; London RE; Williams RS
    EMBO J; 2018 Jul; 37(14):. PubMed ID: 29934293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients.
    Castellotti B; Mariotti C; Rimoldi M; Fancellu R; Plumari M; Caimi S; Uziel G; Nardocci N; Moroni I; Zorzi G; Pareyson D; Di Bella D; Di Donato S; Taroni F; Gellera C
    Neurogenetics; 2011 Aug; 12(3):193-201. PubMed ID: 21465257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single strand that links multiple neuropathologies in human disease.
    Reynolds JJ; Stewart GS
    Brain; 2013 Jan; 136(Pt 1):14-27. PubMed ID: 23365091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage.
    Suraweera A; Becherel OJ; Chen P; Rundle N; Woods R; Nakamura J; Gatei M; Criscuolo C; Filla A; Chessa L; Fusser M; Epe B; Gueven N; Lavin MF
    J Cell Biol; 2007 Jun; 177(6):969-79. PubMed ID: 17562789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TATA-binding protein in neurodegenerative disease.
    van Roon-Mom WM; Reid SJ; Faull RL; Snell RG
    Neuroscience; 2005; 133(4):863-72. PubMed ID: 15916858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular mechanism for spinocerebellar ataxias].
    Onodera O
    Rinsho Shinkeigaku; 2009 Nov; 49(11):750-2. PubMed ID: 20030201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical presentation of ataxia-oculomotor apraxia type 1.
    Shahwan A; Byrd PJ; Taylor AM; Nestor T; Ryan S; King MD
    Dev Med Child Neurol; 2006 Jun; 48(6):529-32. PubMed ID: 16700949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain.
    Iourov IY; Vorsanova SG; Liehr T; Kolotii AD; Yurov YB
    Hum Mol Genet; 2009 Jul; 18(14):2656-69. PubMed ID: 19414482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease.
    Schellenberg MJ; Tumbale PP; Williams RS
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):157-165. PubMed ID: 25637650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity.
    Tumbale P; Williams JS; Schellenberg MJ; Kunkel TA; Williams RS
    Nature; 2014 Feb; 506(7486):111-5. PubMed ID: 24362567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TDP1 mutation causing SCAN1 neurodegenerative syndrome hampers the repair of transcriptional DNA double-strand breaks.
    Geraud M; Cristini A; Salimbeni S; Bery N; Jouffret V; Russo M; Ajello AC; Fernandez Martinez L; Marinello J; Cordelier P; Trouche D; Favre G; Nicolas E; Capranico G; Sordet O
    Cell Rep; 2024 May; 43(5):114214. PubMed ID: 38761375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel mutations in the senataxin DNA/RNA helicase domain in ataxia with oculomotor apraxia 2.
    Fogel BL; Perlman S
    Neurology; 2006 Dec; 67(11):2083-4. PubMed ID: 17159128
    [No Abstract]   [Full Text] [Related]  

  • 55. Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2.
    Kanagaraj R; Mitter R; Kantidakis T; Edwards MM; Benitez A; Chakravarty P; Fu B; Becherel O; Yang F; Lavin MF; Koren A; Stewart A; West SC
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hosting neurotoxicity in polyglutamine disease.
    Liu N; Bonini NM
    Cell; 2006 Dec; 127(7):1299-300. PubMed ID: 17190592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases.
    Nicolaescu E; Beullens M; Lesage B; Keppens S; Himpens B; Bollen M
    Eur J Cell Biol; 2008 Oct; 87(10):817-29. PubMed ID: 18599155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
    Anheim M; Fleury MC; Franques J; Moreira MC; Delaunoy JP; Stoppa-Lyonnet D; Koenig M; Tranchant C
    Arch Neurol; 2008 Jul; 65(7):958-62. PubMed ID: 18625865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation.
    Hawkins AJ; Subler MA; Akopiants K; Wiley JL; Taylor SM; Rice AC; Windle JJ; Valerie K; Povirk LF
    DNA Repair (Amst); 2009 May; 8(5):654-63. PubMed ID: 19211312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?
    Hirano R; Interthal H; Huang C; Nakamura T; Deguchi K; Choi K; Bhattacharjee MB; Arimura K; Umehara F; Izumo S; Northrop JL; Salih MA; Inoue K; Armstrong DL; Champoux JJ; Takashima H; Boerkoel CF
    EMBO J; 2007 Nov; 26(22):4732-43. PubMed ID: 17948061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.